• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[A Case of Advanced Lung Squamous Cell Carcinoma with Idiopathic Pulmonary Fibrosis Treated with Salvage Surgery and Chemotherapy Using Carboplatin plus Nanoparticle Albumin-Bound Paclitaxel].

作者信息

Morio Atsushi

机构信息

Dept. of Chest Surgery, Kobari Hospital.

出版信息

Gan To Kagaku Ryoho. 2018 Aug;45(8):1193-1196.

PMID:30158418
Abstract

We present a case of a 74-year-old man who was a heavy smoker with a performance status of 0(Brinkman indexof 2080). In 2008, he was diagnosed with idiopathic pulmonary fibrosis and was treated with pirfenidone. During follow-up, abnormal chest shadows were observed. In May 2014, he was diagnosed with right middle lobe primary squamous cell carcinoma of the lung(C-T2aN2M1a, contralateral lung metastasis)IV a, for which chemotherapy was immediately initiated. After 3 courses of carboplatin(5 AUC, day 1)plus nanoparticle albumin-bound paclitaxel(100mg/m2, days 1, 8, and 15) treatment, the primary tumor markedly decreased in size(reduction ratio, 93.3%). Moreover, both the mediastinal lymph nodes and lung metastatic lesions disappeared, and the level of tumor marker CYFRA had decreased from 29.5 to 3.4 ng/mL. The patient then underwent thoracoscopic partial resection of the right middle lobe of the lung, as a combination of these chemotherapeutic agents with salvage surgery is the standard treatment regimen for residual middle lobe lung tumors. Subsequently, he was discharged from the hospital without complications. Three courses of the same chemotherapeutic agents were administered post-surgery. As of August 2017, the patient was alive without any recurrence during the outpatient follow-up.

摘要

相似文献

1
[A Case of Advanced Lung Squamous Cell Carcinoma with Idiopathic Pulmonary Fibrosis Treated with Salvage Surgery and Chemotherapy Using Carboplatin plus Nanoparticle Albumin-Bound Paclitaxel].
Gan To Kagaku Ryoho. 2018 Aug;45(8):1193-1196.
2
[Two Cases of Lung Stage ⅢSquamous Cell Carcinoma Treated with Carboplatin (CBDCA)plus Nab-Paclitaxel(Nab-PTX)].
Gan To Kagaku Ryoho. 2019 Jul;46(7):1171-1173.
3
[A Case of Advanced Squamous Cell Lung Cancer with Hemodialysis Treated with Carboplatin and Paclitaxel].
Gan To Kagaku Ryoho. 2018 Aug;45(8):1189-1192.
4
A patient with advanced lung squamous cell carcinoma who failed to benefit from albumin bound paclitaxel plus pembrolizumab achieved partial response with second-line treatment of docetaxel plus pembrolizumab: a case report.一位晚期肺鳞状细胞癌患者,在接受白蛋白结合紫杉醇联合帕博利珠单抗治疗后未获益,二线治疗采用多西他赛联合帕博利珠单抗后获得部分缓解:一例报告。
Ann Palliat Med. 2022 Sep;11(9):3020-3027. doi: 10.21037/apm-22-960.
5
[A case of endobronchial squamous cell lung cancer successfully treated with weekly chemotherapy of carboplatin and paclitaxel].[1例经卡铂和紫杉醇每周化疗成功治疗的支气管内鳞状细胞肺癌病例]
Gan To Kagaku Ryoho. 2003 Jun;30(6):841-4.
6
[Salvage Surgery after Radical Chemotherapy for N3 Non-small Cell Lung Cancer].[N3期非小细胞肺癌根治性化疗后的挽救性手术]
Kyobu Geka. 2018 Mar;71(3):185-189.
7
The Safety and Efficacy of Treatment with Nab-paclitaxel and Carboplatin for Patients with Advanced Squamous Non-small Cell Lung Cancer Concurrent with Idiopathic Interstitial Pneumonias.白蛋白结合型紫杉醇与卡铂联合治疗晚期鳞状非小细胞肺癌合并特发性间质性肺炎患者的安全性和有效性
Intern Med. 2018 Jul 1;57(13):1827-1832. doi: 10.2169/internalmedicine.0404-17. Epub 2018 Feb 9.
8
Carboplatin plus weekly nanoparticle albumin-bound paclitaxel in elderly patients with previously untreated advanced squamous non-small-cell lung cancer selected based on Mini Nutritional Assessment short-form scores: a multicenter phase 2 study.基于简易营养评估简表评分选择的老年初治晚期鳞状非小细胞肺癌患者中卡铂联合每周一次纳米白蛋白结合型紫杉醇的多中心2期研究。
Cancer Chemother Pharmacol. 2017 Sep;80(3):461-467. doi: 10.1007/s00280-017-3385-7. Epub 2017 Jul 7.
9
Effective combination chemotherapy of carboplatin and paclitaxel in the treatment of a recurrent small-cell lung cancer patient.卡铂和紫杉醇联合化疗有效治疗一名复发性小细胞肺癌患者
Gan To Kagaku Ryoho. 2007 Feb;34(2):225-7.
10
Phase II trial of nanoparticle albumin-bound paclitaxel, carboplatin, and bevacizumab in first-line patients with advanced nonsquamous non-small cell lung cancer.白蛋白结合型紫杉醇、卡铂和贝伐珠单抗联合治疗一线晚期非鳞状非小细胞肺癌的 II 期临床试验。
J Thorac Oncol. 2009 Dec;4(12):1537-43. doi: 10.1097/JTO.0b013e3181c0a2f4.